Latest Breaking News On - ஃபைன்ஸ்டீன் நிறுவனங்கள் - Page 16 : comparemela.com

Researchers reveal blood clot risk and anticoagulation benefits in discharged COVID-19 patients Apr 9 2021 In the largest study of its kind, Feinstein Institutes for Medical Research and Northwell COVID-19 Research Consortium researchers reveal blood clot risk and anticoagulation benefits in hospitalized coronavirus disease 2019 (COVID-19) patients who have been recently discharged from the hospital. The report, recently published in the journal Blood, finds that prophylactic anticoagulants reduce the risk of major thromboembolic events and death by 46 percent. Alex C. Spyropoulos, MD, professor at the Feinstein Institutes speaks with a colleague. Image Credit: Feinstein Institutes The prospective multicenter registry, named CORE-19, examined 4,906 adult patients with COVID-19 who were hospitalized at Northwell Health hospitals, New York’s largest health system, between March 1 through May 31, 2020, and was led by Alex C. Spyropoulos, MD, professor at the Feinstein Institutes

New yorkUnited statesKevinj traceyAlexc spyropoulosDimitri giannisResearch consortiumNorthwell healthJanssen pharmaceuticalsNorthwell health research consortiumFeinstein institutes for medical researchFeinstein institutesMedical researchExecutive committeeBroxmeyer fellowshipClinical thrombosisபுதியது யார்க்